InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Kirske David, 首席财务官. Director active across 2 companies, notably CTI Biopharma CORP. Cumulatively, 9 reports have been recorded. Activity tracked since 30 June 2021. The latest transaction was filed on 14 August 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
KIRSKE DAVID is Directeur Financier. He has 9 filings in total, and across the sampled recent filings the most frequent transaction nature is Option exercise, with a period running from 2022-03-11 to 2025-08-14.